First-Month Pressure Control Key to Saving Vision After Severe Glaucoma Surgery
Glaucoma causes irreversible optic nerve damage, leaving clinicians with a single paramount objective once the disease reaches an advanced stage:...
Full Article(1000)
Nearly 4 in 10 Patients Continue Smoking After Cancer Diagnosis: Quitting Slashes Cardiovascular Risk by 36%
A cancer diagnosis is often considered a powerful catalyst for lifestyle changes, yet real-world data reveals that nearly 40% of patients who smoked...
Skin Aging Is More Than Collagen Loss: GC Green Cross Wellbeing Unveils Next-Gen ECM Booster in the Philippines
When skin begins to sag and lose its glow, many people attribute the change solely to declining collagen.
Hanmi Completes Key Phase 2 Dosing for Once-Weekly Rare Disease Drug Efpeglucagon
During normal digestion, dietary carbohydrates convert into glucose that circulates in the blood.
Uijeongbu Eulji University Hospital Launches Beomseok Memorial Cancer Hospital to Streamline Patient Care
Uijeongbu Eulji University Hospital is launching an integrated cancer care system designed to eliminate the logistical...
Choosing Salmon to Lose Weight? How You Eat It Could Add Belly Fat and Strain Blood Vessels
When managing weight, many people reach for salmon instead of chicken breast. Whether served over a salad or stacked on...
Radiation Therapy Shrinks Lymph-Node Tumors in 75% of Advanced Liver Cancer Cases
When hepatocellular carcinoma spreads to the lymph nodes, it is classified as advanced liver cancer, typically...
Crunchy, Nutrient-Dense Lotus Root Takes Center Stage for the Fall Harvest
As September arrives, the harvest season begins for lotus root, the underground stem (rhizome) of the lotus plant.
TV Personality Park Ji-yoon Drops to 55 kg: The Science Behind Her High-Satiety Breakfast Routine
TV personality Park Ji-yoon has drawn widespread attention after revealing a newly defined waistline and a toned...
South Korea’s First Homegrown CAR-T, Rimqarto, Moves Closer to Coverage with 67% Complete Response Rate
Curocell announced on Sept. 4 that its chimeric antigen receptor T-cell (CAR-T) therapy Rimqarto (generic name:...